Patent applications and USPTO patent grants for Astex Pharmaceuticals, Inc..The latest application filed is for "compounds and methods for manufacture of hypomethylating agents".
Patent | Date |
---|---|
Compounds And Methods For Manufacture Of Hypomethylating Agents App 20220144881 - MIYAKE; Masahiro ;   et al. | 2022-05-12 |
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein App 20220000900 - Phiasivongsa; Pasit ;   et al. | 2022-01-06 |
Drug formulations Grant 11,058,705 - Joshi-Hangal , et al. July 13, 2 | 2021-07-13 |
Oligonucleotide analogues incorporating 5-aza-cytosine therein Grant 10,933,079 - Phiasivongsa , et al. March 2, 2 | 2021-03-02 |
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein App 20200215092 - Phiasivongsa; Pasit ;   et al. | 2020-07-09 |
Drug Formulations App 20200155588 - JOSHI-HANGAL; Rajashree ;   et al. | 2020-05-21 |
Drug Combinations App 20200009247 - AZAB; Mohammad ;   et al. | 2020-01-09 |
Drug formulations Grant 10,517,886 - Joshi-Hangal , et al. Dec | 2019-12-31 |
Oligonucleotide analogues incorporating 5-aza-cytosine therein Grant 10,456,415 - Phiasivongsa , et al. Oc | 2019-10-29 |
Drug Formulations App 20180369267 - JOSHI-HANGAL; Rajashree ;   et al. | 2018-12-27 |
Drug formulations Grant 9,913,856 - Joshi-Hangal , et al. March 13, 2 | 2018-03-13 |
Pharmaceutical Compositions For Increasing The Bioavailability Of Poorly Soluble Drugs App 20170360791 - Joshi-Hangal; Rajashree ;   et al. | 2017-12-21 |
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein App 20170035794 - Phiasivongsa; Pasit ;   et al. | 2017-02-09 |
Lyophilized Pharmaceutical Compositions App 20170000738 - JOSHI-HANGAL; Rajashree ;   et al. | 2017-01-05 |
Drug formulations App 20160346310 - JOSHI-HANGAL; Rajashree ;   et al. | 2016-12-01 |
Oligonucleotide analogues incorporating 5-aza-cytosine therein Grant 9,480,698 - Phiasivongsa , et al. November 1, 2 | 2016-11-01 |
Drug formulations Grant 9,381,207 - Joshi-Hangal , et al. July 5, 2 | 2016-07-05 |
Oligonucleotide analogues incorporating 5-aza-cytosine therein Grant 9,358,248 - Phiasivongsa , et al. June 7, 2 | 2016-06-07 |
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein App 20160130296 - Phiasivongsa; Pasit ;   et al. | 2016-05-12 |
Drug Combinations App 20160015805 - AZAB; Mohammad ;   et al. | 2016-01-21 |
Protein kinase inhibitors Grant 8,999,988 - Hurley , et al. April 7, 2 | 2015-04-07 |
Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein App 20130236536 - Phiasivongsa; Pasit ;   et al. | 2013-09-12 |
Oligonucleotide analogues incorporating 5-aza-cytosine therein Grant 8,461,123 - Phiasivongsa , et al. June 11, 2 | 2013-06-11 |
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same Grant 8,445,502 - Bearss , et al. May 21, 2 | 2013-05-21 |
SEC | 0000919722 | Astex Pharmaceuticals, Inc of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.